Moshe Wald, MD - Medicare Urology in Iowa City, IA

Moshe Wald, MD is a medicare enrolled "Urology" physician in Iowa City, Iowa. He graduated from medical school in 1991 and has 33 years of diverse experience with area of expertise as Urology. He is a member of the group practice State University Of Iowa and his current practice location is 200 Hawkins Dr, Iowa City, Iowa. You can reach out to his office (for appointments etc.) via phone at (319) 356-2421.

Moshe Wald is licensed to practice in Iowa (license number 36306) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1205808433.

Contact Information

Moshe Wald, MD
200 Hawkins Dr,
Iowa City, IA 52242-1009
(319) 356-2421
(319) 356-3900



Physician's Profile

Full NameMoshe Wald
GenderMale
SpecialityUrology
Experience33 Years
Location200 Hawkins Dr, Iowa City, Iowa
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Moshe Wald graduated from medical school in 1991
  NPI Data:
  • NPI Number: 1205808433
  • Provider Enumeration Date: 02/02/2006
  • Last Update Date: 12/19/2007
  Medicare PECOS Information:
  • PECOS PAC ID: 7719948488
  • Enrollment ID: I20041026000196

Medical Identifiers

Medical identifiers for Moshe Wald such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1205808433NPI-NPPES
0446351MedicaidIA
37055OtherIAWELLMARK BCBS

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
208800000XUrology 36306 (Iowa)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
University Of Iowa Hospital & ClinicsIowa city, IAHospital
Washington County Hospital And ClinicsWashington, IAHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
State University Of Iowa76188842301476

News Archive

GBI Research says COPD therapeutics pipeline lacks innovation

Analysis from business intelligence provider GBI Research - Frontier Pharma: Chronic Obstructive Pulmonary Disease (COPD) - Identifying and Commercializing First-in-Class Innovation - states that while currently-available drugs aim to manage the frequency and severity of symptoms associated with COPD, none have been shown to modify long-term disease progression.

BioMarin commences GALNS Phase 3 trial in patients with Morquio A Syndrome

BioMarin Pharmaceutical announced today that it has initiated a pivotal Phase 3 trial for N-acetylgalactosamine 6-sulfatase, intended for the treatment of the lysosomal storage disorder Mucopolysaccharidosis Type IVA, also called Morquio A Syndrome.

Mutations in a gene that helps regulate cell division linked to inherited form of fatal lung disease

Mutations in a gene that helps regulate cell division are responsible for some inherited cases of a fatal lung disease, researchers at UT Southwestern Medical Center have found.

Using iPS technology researchers develop new therapies for Parkinson's disease and ALS

Dresden. Dr. Jared Sterneckert is entering the research area "Neurodegenerative Diseases" of the DFG Research Center and Cluster of Excellence at the TU Dresden as a new junior group leader. Since 2006, he has led a team working at the "Max Planck Institute for Molecular Biomedicine" in Münster to develop models of Parkinson's disease and amyotrophic lateral sclerosis.

PAF board member meets First Lady to dicuss denial of health insurance due to pre-existing conditions

The Patient Advocate Foundation (PAF) - a national non-profit organization providing patient services to tens of thousands of patients every year who are unable to obtain access to care because of financial or insurance denials - is pleased to announce that PAF Executive Board Member Venus Gines, founder and CEO of Dia de la Mujer Latina(TM) Inc (Day of the Latin American Woman), provided first-hand testimony today to First Lady Michelle Obama regarding her own and other patients' experiences in being denied health insurance due to pre-existing conditions, and the need to protect patients against such discrimination under healthcare reform.

Read more Medical News

› Verified 2 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Moshe Wald allows following entities to bill medicare on his behalf.
Entity NameState University Of Iowa
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1477554814
PECOS PAC ID: 7618884230
Enrollment ID: O20031107000060

News Archive

GBI Research says COPD therapeutics pipeline lacks innovation

Analysis from business intelligence provider GBI Research - Frontier Pharma: Chronic Obstructive Pulmonary Disease (COPD) - Identifying and Commercializing First-in-Class Innovation - states that while currently-available drugs aim to manage the frequency and severity of symptoms associated with COPD, none have been shown to modify long-term disease progression.

BioMarin commences GALNS Phase 3 trial in patients with Morquio A Syndrome

BioMarin Pharmaceutical announced today that it has initiated a pivotal Phase 3 trial for N-acetylgalactosamine 6-sulfatase, intended for the treatment of the lysosomal storage disorder Mucopolysaccharidosis Type IVA, also called Morquio A Syndrome.

Mutations in a gene that helps regulate cell division linked to inherited form of fatal lung disease

Mutations in a gene that helps regulate cell division are responsible for some inherited cases of a fatal lung disease, researchers at UT Southwestern Medical Center have found.

Using iPS technology researchers develop new therapies for Parkinson's disease and ALS

Dresden. Dr. Jared Sterneckert is entering the research area "Neurodegenerative Diseases" of the DFG Research Center and Cluster of Excellence at the TU Dresden as a new junior group leader. Since 2006, he has led a team working at the "Max Planck Institute for Molecular Biomedicine" in Münster to develop models of Parkinson's disease and amyotrophic lateral sclerosis.

PAF board member meets First Lady to dicuss denial of health insurance due to pre-existing conditions

The Patient Advocate Foundation (PAF) - a national non-profit organization providing patient services to tens of thousands of patients every year who are unable to obtain access to care because of financial or insurance denials - is pleased to announce that PAF Executive Board Member Venus Gines, founder and CEO of Dia de la Mujer Latina(TM) Inc (Day of the Latin American Woman), provided first-hand testimony today to First Lady Michelle Obama regarding her own and other patients' experiences in being denied health insurance due to pre-existing conditions, and the need to protect patients against such discrimination under healthcare reform.

Read more Medical News

› Verified 2 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Moshe Wald is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Moshe Wald, MD
200 Hawkins Dr,
Iowa City, IA 52242-1009

Ph: (319) 356-2421
Moshe Wald, MD
200 Hawkins Dr,
Iowa City, IA 52242-1009

Ph: (319) 356-2421

News Archive

GBI Research says COPD therapeutics pipeline lacks innovation

Analysis from business intelligence provider GBI Research - Frontier Pharma: Chronic Obstructive Pulmonary Disease (COPD) - Identifying and Commercializing First-in-Class Innovation - states that while currently-available drugs aim to manage the frequency and severity of symptoms associated with COPD, none have been shown to modify long-term disease progression.

BioMarin commences GALNS Phase 3 trial in patients with Morquio A Syndrome

BioMarin Pharmaceutical announced today that it has initiated a pivotal Phase 3 trial for N-acetylgalactosamine 6-sulfatase, intended for the treatment of the lysosomal storage disorder Mucopolysaccharidosis Type IVA, also called Morquio A Syndrome.

Mutations in a gene that helps regulate cell division linked to inherited form of fatal lung disease

Mutations in a gene that helps regulate cell division are responsible for some inherited cases of a fatal lung disease, researchers at UT Southwestern Medical Center have found.

Using iPS technology researchers develop new therapies for Parkinson's disease and ALS

Dresden. Dr. Jared Sterneckert is entering the research area "Neurodegenerative Diseases" of the DFG Research Center and Cluster of Excellence at the TU Dresden as a new junior group leader. Since 2006, he has led a team working at the "Max Planck Institute for Molecular Biomedicine" in Münster to develop models of Parkinson's disease and amyotrophic lateral sclerosis.

PAF board member meets First Lady to dicuss denial of health insurance due to pre-existing conditions

The Patient Advocate Foundation (PAF) - a national non-profit organization providing patient services to tens of thousands of patients every year who are unable to obtain access to care because of financial or insurance denials - is pleased to announce that PAF Executive Board Member Venus Gines, founder and CEO of Dia de la Mujer Latina(TM) Inc (Day of the Latin American Woman), provided first-hand testimony today to First Lady Michelle Obama regarding her own and other patients' experiences in being denied health insurance due to pre-existing conditions, and the need to protect patients against such discrimination under healthcare reform.

Read more News

› Verified 2 days ago


Urology Doctors in Iowa City, IA

Jeffrey Spencer Edman, MD
Urology
Medicare: Medicare Enrolled
Practice Location: 200 Hawkins Dr, Iowa City, IA 52242
Phone: 319-384-5643    Fax: 319-356-3900
James Bradley Mason, M.D.
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 200 Hawkins Dr, Iowa City, IA 52242
Phone: 319-356-1616    Fax: 319-356-3900
Charles Haddad Schlaepfer, MD
Urology
Medicare: Medicare Enrolled
Practice Location: 200 Hawkins Dr, Iowa City, IA 52242
Phone: 319-384-5643    
Angelena B. Edwards, M.D.
Urology
Medicare: Medicare Enrolled
Practice Location: 200 Hawkins Dr, Iowa City, IA 52242
Phone: 319-356-0748    
Dr. Paul Thomas Gellhaus, MD
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 200 Hawkins Dr, 3327 Rcp, Iowa City, IA 52242
Phone: 319-356-2421    Fax: 319-356-3900
Dr. Elise Foley Myers, MD
Urology
Medicare: Medicare Enrolled
Practice Location: 200 Hawkins Dr, Iowa City, IA 52242
Phone: 319-384-5643    Fax: 319-356-3900
Dr. Kenan B Ashouri, MD
Urology
Medicare: Medicare Enrolled
Practice Location: 200 Hawkins Dr, Iowa City, IA 52242
Phone: 319-356-2421    Fax: 319-356-3900

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.